CFS Clinical Co-chairs CBI Conference
CFS CLINICAL CO-CHAIRS CBI’S CLINICAL TRIAL BUDGETING & PROJECT MANAGEMENT CONFERENCE
Ernst and Young, CFS, and Shire conduct first time panel on tax risks and mitigation strategies for global investigator site payments
Audubon, PA, July 11, 2013 – CFS Clinical (CFS), a technology-enabled service provider focused on the business and financial management activities for clinical trials, is co-chairing CBI’s 5th Forum on Clinical Trial Budgeting & Project Management Conference from July 17-18, as well as the Pre-Conference Clinical Study Start Up Seminar on July 16th. CFS will co-chair the event at the Doubletree Hotel in Philadelphia with Brenda Medina, Director and Global Head of Clinical Business Operations at Eisai.
“CFS Clinical is proud to co-chair this event. As a Gold Sponsor and CBI partner, we’re committed to promoting best practices in our efforts to transform the way business and financial activities are conducted for clinical trials,” comments Kevin Williams, Vice President Corporate Development & Marketing at CFS Clinical. “Our position as the first and leading provider dedicated to investigator payment and study startup services enables us to share our expertise and provide a unique perspective at events like this across the globe.”
In addition to co-chairing, experts from the CFS team are scheduled as panelists and speakers during sessions throughout the week. Topics include “What Protocol Design, EDC Collector and Site Payments Have in Common” and “Streamlining the Contract and Negotiation Process to Avoid Study Delays.” Also featured is a unique panel discussion exploring the often overlooked tax risks and mitigation strategies when dealing with global investigator site payments. This session features CFS’s April Mulroney, CPA, CA (VP of Global Tax, Treasury, and Client Services) alongside experts from Ernst and Young and Shire.
“CBI is pleased to have CFS Clinical partnering with us for this conference. As experts in their space, we appreciate the value and insights they continue to bring to our programs,” comments Barbara Amberg, Vice President of the Pharmaceutical/Science Group at Advanstar | CBI.
About CFS Clinical:
CFS Clinical (CFS) is a specialty provider focused on the business and financial management activities for clinical trials. The company offers a unique blend of contract, essential site document and cutting-edge investigator payment management services which operate in unison to accelerate cycle times, manage compliance and risk, and stimulate investigator relationships. With our focused expertise, innovative processes, and integrated technology we are able to provide high quality, cost effective service solutions that address critical study startup and financial issues affecting the clinical trials process – including the Sunshine Act. CFS Clinical was founded in 2001 and is headquartered in Audubon, PA.
For more information, visit www.cfsclinical.com.
CBI is the life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries. CBI’s proprietary and intensive market research and product feasibility testing methodology has helped CBI deliver timely and first to market content driven conferences, including annual flag ship events such as PCC (Pharmaceutical Compliance Congress), PAP (Patient Assistance and Access Programs), Pharma Accounting and Reporting Congress, Pharma Forum and Medicaid and Government Pricing Congress. For more information, visit www.cbinet.com.
Contact: Cindy Murray
Posted: July 2013